|
Per rep - (b)(6) 2022 - the stent would not cross the lesion.Per rep - (b)(6) 2022 - how was the procedure completed? by utilizing a competitor stent did any unintended section of the device remain inside the patient¿s body? no.If yes, please describe.Was the patient hospitalized or was there prolonged hospitalization due to this occurrence? no.Did the patient require any additional procedures due to this occurrence? no if yes, please describe.Did the product cause or contribute to the need for additional procedures? no if yes, please specify additional procedures and provide details.Has the complainant reported any adverse effects on the patient due to this occurrence? no.Has the complainant reported that the product caused or contributed to the adverse effects? no.Please specify adverse effects and provide details.Ziv5/ziv6/zfv6: are images of the device or procedure available? n/a, yes, no-no.At what stage of the procedure did the complaint occur? unpacking or preparation of the device, insertion, stent placement, removing the introducer.Insertion.Details of access sheath used (name, fr size, length)? what was the target location for the stent? carotid.Was the product inspected for kinks or damage before use? n/a, yes, no yes.Was the device used percutaneously? n/a, yes, no yes.Was the device flushed through both flushing port before the procedure, as per ifu? n/a, yes, no yes.Was pre-dilation performed ahead of placement of the stent? n/a, yes, no n/a.Was post-dilation performed after the placement of the stent? n/a, yes, no n/a.Details of the wire guide used (name, diameter, hyrdophyllic)? don¿t know.Did the patient exhibit difficult or altered anatomy (if altered please specify how it is altered)? n/a, tortuous, calcified, altered n/a.Was resistance encountered when advancing the wire guide to the target location? n/a, yes, no no.Was resistance encountered when advancing the delivery system to the target location? n/a, yes, no yes.How did the physician deal with this resistance? he removed the device and got a competitor.Was the approach ipsilateral or contralateral? n/a, ipsilateral, contralateral don¿t know.If contralateral, was the bifurcation angle steep? n/a, yes, no don¿t know did the tip of the delivery system cross the target location? n/a, yes, no no.Was the delivery system tracked around a tight angle in the patient anatomy? n/a, yes, no don¿t know.Was the delivery system damaged/kinked/twisted during deployment? n/a, yes, no no.Was the handle pulled towards the hub during deployment? n/a, yes, no device never crossed lesion.Was the delivery system pushed during deployment? n/a, yes, no n/a.Was the stent deployed smoothly / without resistance? n/a, yes, no n/a.If no, please detail any difficulty experienced during deployment: what artery was the stent placed in? n/a.Was the stent fully deployed from the delivery system prior to removal of the delivery system? n/a, yes, no n/a.Did the patient have any pre-existing conditions? n/a, yes, no n/a.If yes, please specify: did the patient require any additional procedures as a result of this event? n/a, yes, no no.What intervention (if any) was required? was the secondary intervention performed during the same procedure as the device failure or was it scheduled for another day? n/a, same procedure, another day were any other defects (other than the complaint issue) observed on the delivery system prior to return (e.G.Kink)? n/a, yes, no.Please specify if yes.Additional information received on 03-jun-2022: the evidence from the investigations suggests that the user didn¿t follow the instructions for use.From the information provided it is known that the complaint device was used in the carotid.As per the ifu, the device is intended for use in the biliary tree.
|